Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gait | 169 | 2023 | 411 | 26.920 |
Why?
|
Parkinson Disease | 138 | 2023 | 847 | 24.000 |
Why?
|
Gait Disorders, Neurologic | 76 | 2022 | 137 | 21.010 |
Why?
|
Accidental Falls | 71 | 2022 | 113 | 16.610 |
Why?
|
Walking | 99 | 2023 | 263 | 16.350 |
Why?
|
Postural Balance | 56 | 2023 | 122 | 10.810 |
Why?
|
Psychomotor Performance | 33 | 2021 | 213 | 6.680 |
Why?
|
Wearable Electronic Devices | 16 | 2023 | 44 | 6.190 |
Why?
|
Aged | 230 | 2023 | 9339 | 5.980 |
Why?
|
Aging | 54 | 2023 | 1572 | 5.320 |
Why?
|
Cognition | 48 | 2023 | 1371 | 5.120 |
Why?
|
Humans | 332 | 2023 | 28462 | 4.950 |
Why?
|
Male | 228 | 2023 | 15367 | 4.670 |
Why?
|
Female | 228 | 2023 | 15793 | 4.580 |
Why?
|
Attention | 27 | 2022 | 138 | 4.440 |
Why?
|
Accelerometry | 20 | 2021 | 88 | 4.300 |
Why?
|
Monitoring, Physiologic | 10 | 2022 | 77 | 3.890 |
Why?
|
Aged, 80 and over | 110 | 2023 | 4904 | 3.870 |
Why?
|
Activities of Daily Living | 25 | 2023 | 612 | 3.760 |
Why?
|
Transcranial Direct Current Stimulation | 7 | 2022 | 9 | 3.720 |
Why?
|
Middle Aged | 128 | 2023 | 9306 | 3.440 |
Why?
|
Executive Function | 17 | 2022 | 115 | 3.140 |
Why?
|
Cognition Disorders | 20 | 2022 | 1020 | 3.050 |
Why?
|
Exercise Therapy | 17 | 2023 | 99 | 3.030 |
Why?
|
Prefrontal Cortex | 14 | 2023 | 149 | 2.870 |
Why?
|
Multiple Sclerosis | 8 | 2023 | 102 | 2.750 |
Why?
|
Geriatric Assessment | 19 | 2020 | 214 | 2.620 |
Why?
|
Exercise Test | 16 | 2023 | 119 | 2.530 |
Why?
|
Task Performance and Analysis | 14 | 2021 | 49 | 2.490 |
Why?
|
Reaction Time | 14 | 2020 | 114 | 2.390 |
Why?
|
Functional Laterality | 12 | 2017 | 67 | 2.340 |
Why?
|
Virtual Reality | 8 | 2022 | 13 | 2.260 |
Why?
|
Neuropsychological Tests | 35 | 2022 | 1254 | 2.220 |
Why?
|
Risk Assessment | 20 | 2022 | 676 | 2.200 |
Why?
|
Tremor | 8 | 2020 | 117 | 2.170 |
Why?
|
Mobility Limitation | 19 | 2020 | 95 | 2.080 |
Why?
|
Motor Activity | 12 | 2020 | 331 | 2.030 |
Why?
|
Physical Therapy Modalities | 14 | 2023 | 75 | 2.020 |
Why?
|
Adult | 75 | 2022 | 8152 | 1.980 |
Why?
|
Cross-Sectional Studies | 32 | 2023 | 939 | 1.860 |
Why?
|
Algorithms | 16 | 2019 | 378 | 1.790 |
Why?
|
Heart Rate | 21 | 2019 | 115 | 1.760 |
Why?
|
Locomotion | 8 | 2017 | 24 | 1.740 |
Why?
|
Exercise | 13 | 2023 | 476 | 1.720 |
Why?
|
Brain | 15 | 2022 | 1699 | 1.700 |
Why?
|
Machine Learning | 8 | 2023 | 71 | 1.660 |
Why?
|
Periodicity | 7 | 2008 | 11 | 1.590 |
Why?
|
Nerve Net | 6 | 2021 | 46 | 1.570 |
Why?
|
Severity of Illness Index | 20 | 2022 | 992 | 1.560 |
Why?
|
Movement | 10 | 2020 | 117 | 1.530 |
Why?
|
Monitoring, Ambulatory | 7 | 2017 | 19 | 1.460 |
Why?
|
Motor Cortex | 5 | 2021 | 17 | 1.430 |
Why?
|
Walking Speed | 10 | 2023 | 40 | 1.310 |
Why?
|
Posture | 10 | 2018 | 68 | 1.300 |
Why?
|
Biomechanical Phenomena | 21 | 2022 | 676 | 1.290 |
Why?
|
Stroke | 7 | 2022 | 278 | 1.290 |
Why?
|
Signal Processing, Computer-Assisted | 10 | 2019 | 32 | 1.230 |
Why?
|
Tai Ji | 8 | 2023 | 9 | 1.230 |
Why?
|
Cognitive Dysfunction | 10 | 2023 | 1072 | 1.220 |
Why?
|
User-Computer Interface | 5 | 2016 | 20 | 1.210 |
Why?
|
Acceleration | 8 | 2016 | 21 | 1.200 |
Why?
|
Quality of Life | 16 | 2022 | 660 | 1.170 |
Why?
|
Risk Factors | 32 | 2020 | 2421 | 1.140 |
Why?
|
Hypokinesia | 6 | 2020 | 23 | 1.130 |
Why?
|
Orthotic Devices | 5 | 2009 | 24 | 1.090 |
Why?
|
Case-Control Studies | 20 | 2019 | 600 | 1.090 |
Why?
|
Subthalamic Nucleus | 3 | 2017 | 19 | 1.050 |
Why?
|
Pilot Projects | 15 | 2022 | 440 | 1.040 |
Why?
|
Models, Biological | 9 | 2015 | 328 | 1.040 |
Why?
|
Time Factors | 25 | 2019 | 1497 | 1.010 |
Why?
|
Feedback, Sensory | 4 | 2018 | 7 | 1.010 |
Why?
|
Electric Stimulation Therapy | 4 | 2009 | 43 | 1.010 |
Why?
|
Freezing Reaction, Cataleptic | 3 | 2018 | 4 | 0.980 |
Why?
|
Antiparkinson Agents | 11 | 2014 | 66 | 0.980 |
Why?
|
Motor Skills | 4 | 2018 | 52 | 0.960 |
Why?
|
Fractals | 11 | 2017 | 21 | 0.950 |
Why?
|
Huntington Disease | 9 | 2022 | 50 | 0.930 |
Why?
|
Independent Living | 9 | 2022 | 320 | 0.920 |
Why?
|
Young Adult | 16 | 2022 | 2100 | 0.910 |
Why?
|
Methylphenidate | 6 | 2009 | 8 | 0.880 |
Why?
|
Deep Brain Stimulation | 3 | 2017 | 39 | 0.870 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 2 | 2023 | 23 | 0.870 |
Why?
|
Central Nervous System Stimulants | 6 | 2009 | 41 | 0.850 |
Why?
|
Gait Ataxia | 3 | 2013 | 5 | 0.840 |
Why?
|
Ataxia | 6 | 2017 | 78 | 0.830 |
Why?
|
Magnetic Resonance Imaging | 15 | 2021 | 1196 | 0.820 |
Why?
|
Virtual Reality Exposure Therapy | 4 | 2017 | 7 | 0.820 |
Why?
|
Levodopa | 8 | 2020 | 47 | 0.810 |
Why?
|
Fear | 5 | 2016 | 48 | 0.800 |
Why?
|
Disability Evaluation | 7 | 2019 | 293 | 0.790 |
Why?
|
Transcranial Magnetic Stimulation | 3 | 2021 | 17 | 0.790 |
Why?
|
Frailty | 4 | 2023 | 35 | 0.780 |
Why?
|
Blood Pressure | 7 | 2020 | 204 | 0.770 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 4 | 2018 | 37 | 0.760 |
Why?
|
Time and Motion Studies | 4 | 2021 | 18 | 0.760 |
Why?
|
Paresis | 5 | 2014 | 17 | 0.760 |
Why?
|
Fatigue | 3 | 2019 | 65 | 0.760 |
Why?
|
Depression | 5 | 2018 | 454 | 0.760 |
Why?
|
Problem Solving | 8 | 2012 | 47 | 0.730 |
Why?
|
Risk | 9 | 2018 | 208 | 0.730 |
Why?
|
Frontal Lobe | 4 | 2018 | 83 | 0.720 |
Why?
|
Brain Mapping | 6 | 2020 | 168 | 0.720 |
Why?
|
Double-Blind Method | 7 | 2021 | 424 | 0.720 |
Why?
|
Cognitive Reserve | 2 | 2018 | 39 | 0.700 |
Why?
|
Martial Arts | 1 | 2020 | 4 | 0.680 |
Why?
|
Swimming | 1 | 2020 | 8 | 0.680 |
Why?
|
Muscle Rigidity | 2 | 2019 | 20 | 0.680 |
Why?
|
Arm | 3 | 2016 | 84 | 0.670 |
Why?
|
Disabled Persons | 4 | 2023 | 125 | 0.670 |
Why?
|
Avoidance Learning | 1 | 2019 | 6 | 0.670 |
Why?
|
Pattern Recognition, Automated | 1 | 2019 | 7 | 0.670 |
Why?
|
Statistics, Nonparametric | 8 | 2017 | 124 | 0.660 |
Why?
|
Sensation Disorders | 2 | 2013 | 11 | 0.660 |
Why?
|
Follow-Up Studies | 12 | 2020 | 1868 | 0.650 |
Why?
|
Reproducibility of Results | 15 | 2022 | 726 | 0.650 |
Why?
|
Torso | 2 | 2016 | 7 | 0.640 |
Why?
|
Laboratories | 1 | 2019 | 9 | 0.640 |
Why?
|
Prospective Studies | 17 | 2022 | 1810 | 0.640 |
Why?
|
Extremities | 3 | 2017 | 28 | 0.620 |
Why?
|
Sleep Wake Disorders | 1 | 2020 | 130 | 0.610 |
Why?
|
Treatment Outcome | 16 | 2018 | 3619 | 0.600 |
Why?
|
Age Factors | 12 | 2019 | 793 | 0.600 |
Why?
|
Longitudinal Studies | 14 | 2023 | 1391 | 0.590 |
Why?
|
Self Report | 4 | 2022 | 226 | 0.580 |
Why?
|
Spectroscopy, Near-Infrared | 8 | 2021 | 10 | 0.570 |
Why?
|
Ischemic Attack, Transient | 2 | 2015 | 18 | 0.570 |
Why?
|
Acoustic Stimulation | 5 | 2018 | 57 | 0.570 |
Why?
|
Learning | 3 | 2019 | 71 | 0.560 |
Why?
|
Chronic Pain | 4 | 2020 | 114 | 0.560 |
Why?
|
Dementia | 5 | 2022 | 580 | 0.550 |
Why?
|
Caudate Nucleus | 2 | 2018 | 11 | 0.540 |
Why?
|
Foot | 4 | 2020 | 45 | 0.540 |
Why?
|
Telemetry | 2 | 2013 | 11 | 0.530 |
Why?
|
Analysis of Variance | 8 | 2012 | 276 | 0.520 |
Why?
|
Alzheimer Disease | 7 | 2023 | 2148 | 0.520 |
Why?
|
Neurologic Examination | 9 | 2021 | 115 | 0.510 |
Why?
|
Medical Informatics Applications | 1 | 2015 | 1 | 0.510 |
Why?
|
Biomedical Engineering | 1 | 2015 | 5 | 0.510 |
Why?
|
Movement Disorders | 4 | 2020 | 91 | 0.490 |
Why?
|
Uncertainty | 1 | 2015 | 9 | 0.490 |
Why?
|
Cerebral Cortex | 2 | 2018 | 164 | 0.480 |
Why?
|
Electroencephalography | 6 | 2022 | 80 | 0.480 |
Why?
|
Residence Characteristics | 2 | 2016 | 216 | 0.480 |
Why?
|
Memory | 8 | 2019 | 308 | 0.460 |
Why?
|
Mutation | 4 | 2018 | 349 | 0.460 |
Why?
|
Neurons | 1 | 2017 | 341 | 0.450 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2013 | 4 | 0.440 |
Why?
|
Smartphone | 3 | 2019 | 17 | 0.430 |
Why?
|
Cross-Over Studies | 3 | 2022 | 64 | 0.420 |
Why?
|
Myelin Sheath | 1 | 2013 | 27 | 0.410 |
Why?
|
Reference Values | 10 | 2012 | 199 | 0.410 |
Why?
|
Parkinsonian Disorders | 4 | 2021 | 227 | 0.410 |
Why?
|
Connectome | 3 | 2021 | 12 | 0.410 |
Why?
|
Thinking | 2 | 2010 | 18 | 0.410 |
Why?
|
Neuroimaging | 4 | 2020 | 133 | 0.400 |
Why?
|
Wireless Technology | 1 | 2011 | 2 | 0.390 |
Why?
|
Remote Sensing Technology | 1 | 2011 | 3 | 0.390 |
Why?
|
Musculoskeletal Pain | 2 | 2023 | 21 | 0.390 |
Why?
|
Cues | 4 | 2018 | 50 | 0.390 |
Why?
|
Amyotrophic Lateral Sclerosis | 2 | 2023 | 24 | 0.380 |
Why?
|
Cohort Studies | 11 | 2020 | 1948 | 0.380 |
Why?
|
Biofeedback, Psychology | 1 | 2011 | 4 | 0.380 |
Why?
|
Stereotyping | 3 | 2008 | 16 | 0.380 |
Why?
|
Autonomic Nervous System | 3 | 2009 | 19 | 0.370 |
Why?
|
Hypertension | 4 | 2020 | 226 | 0.370 |
Why?
|
Adolescent | 11 | 2019 | 2324 | 0.370 |
Why?
|
Dopamine | 2 | 2020 | 88 | 0.370 |
Why?
|
Mental Status Schedule | 5 | 2017 | 98 | 0.360 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2020 | 329 | 0.360 |
Why?
|
Multitasking Behavior | 3 | 2020 | 3 | 0.360 |
Why?
|
Models, Statistical | 6 | 2020 | 128 | 0.360 |
Why?
|
Evoked Potentials | 2 | 2021 | 14 | 0.350 |
Why?
|
Axis, Cervical Vertebra | 1 | 2010 | 9 | 0.350 |
Why?
|
Neurological Rehabilitation | 2 | 2020 | 5 | 0.350 |
Why?
|
Heterozygote | 1 | 2011 | 103 | 0.350 |
Why?
|
Health Status Indicators | 2 | 2008 | 75 | 0.350 |
Why?
|
Patient Outcome Assessment | 3 | 2019 | 41 | 0.350 |
Why?
|
Central Nervous System | 4 | 2017 | 58 | 0.340 |
Why?
|
Adaptation, Physiological | 4 | 2018 | 53 | 0.340 |
Why?
|
Eye Movements | 3 | 2020 | 12 | 0.340 |
Why?
|
Electrocardiography | 9 | 2010 | 109 | 0.330 |
Why?
|
Geriatrics | 2 | 2007 | 9 | 0.330 |
Why?
|
Dominance, Cerebral | 1 | 2009 | 16 | 0.320 |
Why?
|
Mobile Applications | 3 | 2019 | 32 | 0.320 |
Why?
|
Orientation | 2 | 2013 | 6 | 0.320 |
Why?
|
Artificial Limbs | 1 | 2009 | 7 | 0.320 |
Why?
|
Predictive Value of Tests | 7 | 2013 | 494 | 0.310 |
Why?
|
Neural Pathways | 4 | 2020 | 73 | 0.310 |
Why?
|
Linear Models | 5 | 2017 | 255 | 0.310 |
Why?
|
Brain Injuries | 1 | 2009 | 36 | 0.310 |
Why?
|
Statistics as Topic | 6 | 2017 | 113 | 0.300 |
Why?
|
Exercise Tolerance | 2 | 2007 | 32 | 0.300 |
Why?
|
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 4 | 2018 | 5 | 0.290 |
Why?
|
Attitude to Health | 2 | 2017 | 105 | 0.290 |
Why?
|
Touch | 1 | 2007 | 9 | 0.290 |
Why?
|
Biological Clocks | 1 | 2007 | 17 | 0.280 |
Why?
|
Early Diagnosis | 3 | 2013 | 68 | 0.280 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2017 | 188 | 0.280 |
Why?
|
Stroop Test | 2 | 2018 | 3 | 0.280 |
Why?
|
Hearing | 1 | 2007 | 21 | 0.280 |
Why?
|
Feedback | 1 | 2007 | 33 | 0.280 |
Why?
|
Mental Processes | 2 | 2006 | 20 | 0.280 |
Why?
|
Telemedicine | 2 | 2020 | 119 | 0.280 |
Why?
|
Health Status | 5 | 2016 | 228 | 0.280 |
Why?
|
Boston | 7 | 2019 | 27 | 0.280 |
Why?
|
Logistic Models | 6 | 2018 | 397 | 0.280 |
Why?
|
Physical Fitness | 5 | 2019 | 57 | 0.270 |
Why?
|
Muscle, Skeletal | 4 | 2021 | 398 | 0.270 |
Why?
|
Shoes | 2 | 2017 | 33 | 0.270 |
Why?
|
Feasibility Studies | 5 | 2016 | 233 | 0.270 |
Why?
|
Antidepressive Agents | 1 | 2007 | 97 | 0.270 |
Why?
|
Stress, Psychological | 2 | 2011 | 243 | 0.270 |
Why?
|
Neurodegenerative Diseases | 2 | 2019 | 124 | 0.260 |
Why?
|
Sex Factors | 7 | 2019 | 480 | 0.260 |
Why?
|
Sensation | 3 | 2011 | 12 | 0.260 |
Why?
|
Knee Joint | 4 | 2022 | 754 | 0.260 |
Why?
|
Regression Analysis | 5 | 2015 | 267 | 0.250 |
Why?
|
Basal Ganglia | 3 | 2020 | 16 | 0.250 |
Why?
|
Heart Failure | 8 | 2001 | 175 | 0.250 |
Why?
|
Biomarkers | 3 | 2018 | 601 | 0.250 |
Why?
|
Space Perception | 2 | 2020 | 24 | 0.240 |
Why?
|
Incidence | 4 | 2021 | 779 | 0.240 |
Why?
|
Range of Motion, Articular | 3 | 2019 | 725 | 0.230 |
Why?
|
Demography | 3 | 2014 | 75 | 0.230 |
Why?
|
Multivariate Analysis | 6 | 2016 | 334 | 0.230 |
Why?
|
Chorea | 2 | 2022 | 5 | 0.230 |
Why?
|
Prognosis | 6 | 2019 | 824 | 0.230 |
Why?
|
Patient Satisfaction | 4 | 2013 | 329 | 0.230 |
Why?
|
Bipolar Disorder | 1 | 2004 | 109 | 0.230 |
Why?
|
Sleep | 2 | 2020 | 355 | 0.230 |
Why?
|
Depressive Disorder, Major | 1 | 2004 | 102 | 0.220 |
Why?
|
Cerebellum | 3 | 2020 | 43 | 0.220 |
Why?
|
Kinetics | 4 | 2018 | 185 | 0.220 |
Why?
|
Muscle Contraction | 2 | 2021 | 68 | 0.220 |
Why?
|
Neck Pain | 1 | 2023 | 28 | 0.210 |
Why?
|
Thalamus | 2 | 2020 | 16 | 0.210 |
Why?
|
Myoclonic Epilepsy, Juvenile | 1 | 2023 | 1 | 0.210 |
Why?
|
Gray Matter | 2 | 2020 | 55 | 0.210 |
Why?
|
Research Design | 3 | 2022 | 208 | 0.210 |
Why?
|
Chiropractic | 1 | 2022 | 1 | 0.210 |
Why?
|
Ambulatory Care Facilities | 1 | 2023 | 40 | 0.210 |
Why?
|
Wrist | 1 | 2022 | 17 | 0.200 |
Why?
|
Disease Progression | 3 | 2017 | 719 | 0.200 |
Why?
|
Surveys and Questionnaires | 6 | 2019 | 1216 | 0.200 |
Why?
|
Caregivers | 2 | 2022 | 203 | 0.200 |
Why?
|
Mental Health | 2 | 2001 | 123 | 0.200 |
Why?
|
Putamen | 3 | 2018 | 21 | 0.200 |
Why?
|
Therapy, Computer-Assisted | 2 | 2014 | 11 | 0.200 |
Why?
|
Basal Ganglia Diseases | 2 | 2000 | 6 | 0.200 |
Why?
|
Stochastic Processes | 1 | 2001 | 13 | 0.200 |
Why?
|
Comorbidity | 5 | 2016 | 502 | 0.190 |
Why?
|
Brain Ischemia | 1 | 2022 | 63 | 0.190 |
Why?
|
Nonlinear Dynamics | 5 | 2009 | 13 | 0.190 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 52 | 0.190 |
Why?
|
Healthy Volunteers | 2 | 2019 | 44 | 0.190 |
Why?
|
Child | 5 | 2018 | 1423 | 0.190 |
Why?
|
Equipment Design | 5 | 2017 | 154 | 0.190 |
Why?
|
Brain Waves | 1 | 2021 | 5 | 0.190 |
Why?
|
Homeostasis | 3 | 2020 | 69 | 0.190 |
Why?
|
Essential Tremor | 1 | 2021 | 5 | 0.190 |
Why?
|
Lewy Body Disease | 1 | 2022 | 99 | 0.190 |
Why?
|
Telerehabilitation | 1 | 2021 | 4 | 0.190 |
Why?
|
Eye Movement Measurements | 2 | 2018 | 2 | 0.180 |
Why?
|
Minority Groups | 1 | 2001 | 87 | 0.180 |
Why?
|
Lower Extremity | 1 | 2021 | 40 | 0.180 |
Why?
|
Paraplegia | 2 | 1991 | 6 | 0.180 |
Why?
|
Anticipation, Psychological | 1 | 2020 | 5 | 0.180 |
Why?
|
Social Class | 1 | 2001 | 68 | 0.180 |
Why?
|
Ankle | 1 | 2020 | 24 | 0.170 |
Why?
|
Quality of Health Care | 1 | 2001 | 126 | 0.170 |
Why?
|
Stroke Rehabilitation | 2 | 2011 | 23 | 0.170 |
Why?
|
Cardiovascular Diseases | 2 | 2001 | 373 | 0.170 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2001 | 244 | 0.170 |
Why?
|
Walk Test | 1 | 2019 | 9 | 0.170 |
Why?
|
Computer Graphics | 2 | 2013 | 6 | 0.170 |
Why?
|
Prejudice | 1 | 1999 | 33 | 0.160 |
Why?
|
Sensitivity and Specificity | 6 | 2012 | 520 | 0.160 |
Why?
|
Weight-Bearing | 2 | 2017 | 171 | 0.160 |
Why?
|
Nervous System Diseases | 4 | 2019 | 121 | 0.160 |
Why?
|
Event-Related Potentials, P300 | 1 | 2018 | 2 | 0.160 |
Why?
|
Health | 2 | 2017 | 10 | 0.160 |
Why?
|
Psychiatric Status Rating Scales | 4 | 2005 | 329 | 0.160 |
Why?
|
Diagnostic Techniques, Neurological | 1 | 2018 | 11 | 0.160 |
Why?
|
Athletes | 1 | 2019 | 89 | 0.160 |
Why?
|
Mental Recall | 2 | 2009 | 71 | 0.150 |
Why?
|
Magnetic Phenomena | 1 | 2018 | 1 | 0.150 |
Why?
|
Auditory Perception | 1 | 2018 | 43 | 0.150 |
Why?
|
Fixation, Ocular | 1 | 2018 | 3 | 0.150 |
Why?
|
Software | 2 | 2013 | 67 | 0.150 |
Why?
|
Osteoarthritis, Knee | 1 | 2022 | 363 | 0.150 |
Why?
|
Models, Cardiovascular | 4 | 2009 | 14 | 0.150 |
Why?
|
Circadian Rhythm | 1 | 2021 | 297 | 0.150 |
Why?
|
Genetic Predisposition to Disease | 3 | 2022 | 382 | 0.150 |
Why?
|
Neuronal Plasticity | 1 | 2018 | 47 | 0.150 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 772 | 0.150 |
Why?
|
Qigong | 1 | 2017 | 1 | 0.140 |
Why?
|
Education | 1 | 2017 | 46 | 0.140 |
Why?
|
Psychometrics | 2 | 2010 | 242 | 0.140 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 1997 | 37 | 0.140 |
Why?
|
Survival Analysis | 3 | 2012 | 267 | 0.140 |
Why?
|
United States | 6 | 2020 | 2185 | 0.140 |
Why?
|
Galvanic Skin Response | 2 | 2015 | 7 | 0.140 |
Why?
|
Communication Barriers | 1 | 2016 | 4 | 0.140 |
Why?
|
Corpus Striatum | 1 | 2017 | 66 | 0.140 |
Why?
|
Video Recording | 2 | 2013 | 35 | 0.140 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2015 | 10 | 0.140 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 1997 | 63 | 0.130 |
Why?
|
Prodromal Symptoms | 1 | 2016 | 19 | 0.130 |
Why?
|
Mexican Americans | 1 | 2016 | 30 | 0.130 |
Why?
|
Species Specificity | 1 | 2016 | 41 | 0.130 |
Why?
|
Pain Measurement | 4 | 2020 | 473 | 0.130 |
Why?
|
Formative Feedback | 1 | 2016 | 3 | 0.130 |
Why?
|
Prosthesis Design | 2 | 2009 | 503 | 0.130 |
Why?
|
Bone Density | 1 | 2017 | 149 | 0.130 |
Why?
|
Electrodes | 1 | 2015 | 12 | 0.130 |
Why?
|
Atrial Natriuretic Factor | 1 | 1995 | 3 | 0.120 |
Why?
|
Hypotension, Orthostatic | 1 | 1995 | 11 | 0.120 |
Why?
|
Electronics | 1 | 1995 | 11 | 0.120 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 196 | 0.120 |
Why?
|
Observer Variation | 2 | 2013 | 104 | 0.120 |
Why?
|
Rotation | 1 | 2015 | 142 | 0.120 |
Why?
|
Data Interpretation, Statistical | 3 | 2013 | 83 | 0.120 |
Why?
|
Single-Blind Method | 2 | 2013 | 111 | 0.120 |
Why?
|
Phenylcarbamates | 1 | 2014 | 1 | 0.120 |
Why?
|
Patient Reported Outcome Measures | 1 | 2019 | 508 | 0.120 |
Why?
|
Affect | 1 | 2014 | 63 | 0.120 |
Why?
|
Genetic Markers | 2 | 2011 | 36 | 0.110 |
Why?
|
Automation | 1 | 2014 | 9 | 0.110 |
Why?
|
Disease Models, Animal | 1 | 2017 | 628 | 0.110 |
Why?
|
Discriminant Analysis | 1 | 2013 | 9 | 0.110 |
Why?
|
Imagination | 1 | 2013 | 3 | 0.110 |
Why?
|
Neurotransmitter Agents | 1 | 2013 | 17 | 0.110 |
Why?
|
Physical Education and Training | 1 | 2013 | 5 | 0.110 |
Why?
|
Neuroprotective Agents | 1 | 2014 | 55 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 179 | 0.110 |
Why?
|
Functional Neuroimaging | 3 | 2018 | 7 | 0.110 |
Why?
|
Positron-Emission Tomography | 1 | 2013 | 90 | 0.110 |
Why?
|
Diffusion Tensor Imaging | 1 | 2013 | 66 | 0.110 |
Why?
|
Hand | 2 | 2021 | 40 | 0.110 |
Why?
|
Early Medical Intervention | 1 | 2013 | 15 | 0.100 |
Why?
|
Atrophy | 1 | 2013 | 91 | 0.100 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2013 | 80 | 0.100 |
Why?
|
Somatosensory Disorders | 1 | 2012 | 11 | 0.100 |
Why?
|
Time Perception | 1 | 2012 | 6 | 0.100 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2012 | 28 | 0.100 |
Why?
|
Image Enhancement | 1 | 2012 | 48 | 0.100 |
Why?
|
Physical Endurance | 3 | 2016 | 8 | 0.100 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2012 | 69 | 0.100 |
Why?
|
Frail Elderly | 2 | 2023 | 53 | 0.100 |
Why?
|
Odds Ratio | 4 | 2017 | 274 | 0.100 |
Why?
|
Biosensing Techniques | 1 | 2011 | 11 | 0.100 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2012 | 96 | 0.100 |
Why?
|
Probability | 2 | 2009 | 91 | 0.090 |
Why?
|
Musculoskeletal Physiological Phenomena | 1 | 2011 | 2 | 0.090 |
Why?
|
Prevalence | 4 | 2014 | 473 | 0.090 |
Why?
|
Muscles | 1 | 1991 | 57 | 0.090 |
Why?
|
Program Evaluation | 1 | 2011 | 135 | 0.090 |
Why?
|
Diagnosis, Differential | 3 | 2021 | 371 | 0.090 |
Why?
|
Outpatients | 2 | 2008 | 59 | 0.090 |
Why?
|
Computer Systems | 1 | 2009 | 7 | 0.090 |
Why?
|
Self-Help Devices | 1 | 2009 | 5 | 0.080 |
Why?
|
Musculoskeletal System | 1 | 2009 | 7 | 0.080 |
Why?
|
Electric Stimulation | 1 | 1990 | 49 | 0.080 |
Why?
|
Consensus | 2 | 2021 | 98 | 0.080 |
Why?
|
Baltimore | 3 | 2018 | 10 | 0.080 |
Why?
|
Biophysical Phenomena | 1 | 2009 | 27 | 0.080 |
Why?
|
Sampling Studies | 1 | 2009 | 31 | 0.080 |
Why?
|
Color Perception | 1 | 2009 | 5 | 0.080 |
Why?
|
Self-Assessment | 1 | 2009 | 30 | 0.080 |
Why?
|
Normal Distribution | 2 | 2003 | 5 | 0.080 |
Why?
|
Peroneal Nerve | 1 | 2009 | 5 | 0.080 |
Why?
|
Semantics | 1 | 2009 | 19 | 0.080 |
Why?
|
Israel | 1 | 2009 | 17 | 0.080 |
Why?
|
Organ Size | 2 | 2020 | 107 | 0.080 |
Why?
|
Gait Apraxia | 1 | 2008 | 1 | 0.080 |
Why?
|
Pattern Recognition, Visual | 1 | 2009 | 27 | 0.080 |
Why?
|
Chi-Square Distribution | 2 | 2007 | 146 | 0.080 |
Why?
|
Psychological Tests | 1 | 2008 | 53 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2009 | 306 | 0.080 |
Why?
|
Perception | 1 | 2009 | 76 | 0.080 |
Why?
|
Arthralgia | 1 | 2009 | 125 | 0.080 |
Why?
|
Interpersonal Relations | 1 | 2009 | 104 | 0.070 |
Why?
|
Radio Waves | 1 | 2008 | 9 | 0.070 |
Why?
|
Perceptual Masking | 1 | 2008 | 12 | 0.070 |
Why?
|
Vocabulary | 1 | 2008 | 13 | 0.070 |
Why?
|
Attitude | 1 | 2008 | 36 | 0.070 |
Why?
|
Leg | 2 | 2005 | 53 | 0.070 |
Why?
|
Genotype | 2 | 2022 | 352 | 0.070 |
Why?
|
Peripheral Nervous System | 1 | 2007 | 1 | 0.070 |
Why?
|
Apraxias | 1 | 2007 | 1 | 0.070 |
Why?
|
Visual Cortex | 1 | 2007 | 7 | 0.070 |
Why?
|
Psychophysiology | 1 | 2007 | 6 | 0.070 |
Why?
|
Veterans Disability Claims | 1 | 2007 | 1 | 0.070 |
Why?
|
Trauma Severity Indices | 1 | 2007 | 10 | 0.070 |
Why?
|
Parietal Lobe | 1 | 2007 | 17 | 0.070 |
Why?
|
Gyrus Cinguli | 1 | 2007 | 17 | 0.070 |
Why?
|
Psychotropic Drugs | 1 | 2007 | 28 | 0.070 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 236 | 0.070 |
Why?
|
Recovery of Function | 1 | 2009 | 300 | 0.070 |
Why?
|
Anxiety | 1 | 2008 | 161 | 0.070 |
Why?
|
Verbal Behavior | 1 | 2007 | 18 | 0.070 |
Why?
|
Dementia, Vascular | 1 | 2007 | 45 | 0.070 |
Why?
|
Hippocampus | 2 | 2020 | 281 | 0.070 |
Why?
|
Visual Perception | 1 | 2007 | 35 | 0.070 |
Why?
|
Choice Behavior | 1 | 2007 | 47 | 0.070 |
Why?
|
Systole | 3 | 2002 | 16 | 0.070 |
Why?
|
Oscillometry | 2 | 2003 | 5 | 0.060 |
Why?
|
Body Mass Index | 2 | 2019 | 466 | 0.060 |
Why?
|
Anthropometry | 1 | 2005 | 36 | 0.060 |
Why?
|
Retrospective Studies | 5 | 2014 | 3612 | 0.060 |
Why?
|
Neoplasms | 2 | 2001 | 242 | 0.060 |
Why?
|
Extrapyramidal Tracts | 1 | 2005 | 1 | 0.060 |
Why?
|
Urinary Incontinence | 1 | 2005 | 23 | 0.060 |
Why?
|
Immobilization | 1 | 2004 | 14 | 0.060 |
Why?
|
Fourier Analysis | 2 | 1995 | 8 | 0.060 |
Why?
|
Diagnostic Imaging | 1 | 2005 | 79 | 0.060 |
Why?
|
Confidence Intervals | 2 | 2017 | 97 | 0.060 |
Why?
|
Mass Screening | 2 | 2005 | 185 | 0.060 |
Why?
|
Meditation | 1 | 2004 | 23 | 0.060 |
Why?
|
Emotions | 2 | 2002 | 87 | 0.060 |
Why?
|
Multiple System Atrophy | 1 | 2004 | 38 | 0.050 |
Why?
|
Heart Diseases | 2 | 1995 | 68 | 0.050 |
Why?
|
Receptors, CCR5 | 1 | 2022 | 14 | 0.050 |
Why?
|
Protective Factors | 1 | 2022 | 27 | 0.050 |
Why?
|
Gene Frequency | 1 | 2022 | 60 | 0.050 |
Why?
|
Photic Stimulation | 1 | 2002 | 37 | 0.050 |
Why?
|
Observational Studies as Topic | 1 | 2022 | 19 | 0.050 |
Why?
|
Negotiating | 1 | 2022 | 4 | 0.050 |
Why?
|
ROC Curve | 2 | 2017 | 145 | 0.050 |
Why?
|
Seizures | 1 | 2023 | 65 | 0.050 |
Why?
|
Respiratory Mechanics | 1 | 2002 | 9 | 0.050 |
Why?
|
Disease | 1 | 2002 | 6 | 0.050 |
Why?
|
Oxyhemoglobins | 1 | 2021 | 1 | 0.050 |
Why?
|
Massachusetts | 1 | 2001 | 19 | 0.050 |
Why?
|
Computer Simulation | 1 | 2023 | 204 | 0.050 |
Why?
|
Physician's Role | 1 | 2001 | 19 | 0.050 |
Why?
|
Weight Lifting | 1 | 2001 | 9 | 0.050 |
Why?
|
Doxorubicin | 2 | 2001 | 55 | 0.050 |
Why?
|
Pain | 2 | 2022 | 406 | 0.050 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2020 | 5 | 0.050 |
Why?
|
Blood Flow Velocity | 1 | 2020 | 18 | 0.050 |
Why?
|
Drug Therapy | 1 | 2000 | 9 | 0.040 |
Why?
|
Physiology | 1 | 2000 | 4 | 0.040 |
Why?
|
Databases as Topic | 1 | 2000 | 15 | 0.040 |
Why?
|
Afferent Pathways | 1 | 2020 | 4 | 0.040 |
Why?
|
Arousal | 1 | 2000 | 50 | 0.040 |
Why?
|
Self Concept | 1 | 2000 | 43 | 0.040 |
Why?
|
Neoplasm Staging | 2 | 2001 | 372 | 0.040 |
Why?
|
Leukocytosis | 1 | 2000 | 4 | 0.040 |
Why?
|
Epilepsies, Partial | 1 | 1999 | 13 | 0.040 |
Why?
|
Leukoencephalopathies | 1 | 2019 | 12 | 0.040 |
Why?
|
Mortality | 1 | 2020 | 88 | 0.040 |
Why?
|
Systems Analysis | 1 | 2019 | 4 | 0.040 |
Why?
|
Fitness Trackers | 1 | 2019 | 14 | 0.040 |
Why?
|
Device Approval | 1 | 2019 | 4 | 0.040 |
Why?
|
Canada | 1 | 2019 | 51 | 0.040 |
Why?
|
Ventricular Function, Left | 1 | 1999 | 40 | 0.040 |
Why?
|
Respiration | 3 | 2004 | 35 | 0.040 |
Why?
|
Delphi Technique | 1 | 2019 | 27 | 0.040 |
Why?
|
Internet | 1 | 2000 | 98 | 0.040 |
Why?
|
Computer Security | 1 | 2019 | 6 | 0.040 |
Why?
|
Neutrophils | 1 | 2000 | 106 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 352 | 0.040 |
Why?
|
Body Height | 1 | 1999 | 37 | 0.040 |
Why?
|
Animals | 5 | 2017 | 3798 | 0.040 |
Why?
|
Models, Neurological | 1 | 2019 | 26 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2017 | 438 | 0.040 |
Why?
|
Health Services Needs and Demand | 1 | 2019 | 59 | 0.040 |
Why?
|
Trail Making Test | 1 | 2018 | 4 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2000 | 141 | 0.040 |
Why?
|
Random Allocation | 1 | 2018 | 129 | 0.040 |
Why?
|
Globus Pallidus | 1 | 2018 | 11 | 0.040 |
Why?
|
Spatio-Temporal Analysis | 1 | 2018 | 4 | 0.040 |
Why?
|
Support Vector Machine | 1 | 2018 | 7 | 0.040 |
Why?
|
Nucleus Accumbens | 1 | 2018 | 14 | 0.040 |
Why?
|
Glucosylceramidase | 1 | 2018 | 17 | 0.040 |
Why?
|
White Matter | 1 | 2020 | 142 | 0.040 |
Why?
|
Visual Acuity | 1 | 2018 | 41 | 0.040 |
Why?
|
Muscle Strength | 1 | 2019 | 138 | 0.040 |
Why?
|
Recombination, Genetic | 1 | 1997 | 5 | 0.040 |
Why?
|
Gene Rearrangement | 1 | 1997 | 10 | 0.040 |
Why?
|
Amygdala | 1 | 2018 | 43 | 0.040 |
Why?
|
Genome | 1 | 1997 | 9 | 0.040 |
Why?
|
Vincristine | 1 | 1997 | 21 | 0.040 |
Why?
|
Women's Health | 1 | 1999 | 177 | 0.040 |
Why?
|
Memory, Short-Term | 1 | 2018 | 103 | 0.040 |
Why?
|
Models, Theoretical | 1 | 2018 | 82 | 0.040 |
Why?
|
Intelligence Tests | 1 | 2017 | 15 | 0.040 |
Why?
|
Cyclophosphamide | 1 | 1997 | 49 | 0.040 |
Why?
|
Preventive Health Services | 1 | 2017 | 15 | 0.040 |
Why?
|
Prednisone | 1 | 1997 | 65 | 0.040 |
Why?
|
Guideline Adherence | 1 | 2017 | 65 | 0.040 |
Why?
|
Behavior Therapy | 1 | 2018 | 92 | 0.040 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 1997 | 35 | 0.030 |
Why?
|
Oxygen | 1 | 2017 | 81 | 0.030 |
Why?
|
Family | 1 | 2018 | 111 | 0.030 |
Why?
|
Femur Neck | 1 | 2017 | 21 | 0.030 |
Why?
|
Pressure | 1 | 2017 | 64 | 0.030 |
Why?
|
Child, Preschool | 1 | 1999 | 692 | 0.030 |
Why?
|
Liver | 1 | 1997 | 160 | 0.030 |
Why?
|
Musculoskeletal Diseases | 1 | 1997 | 46 | 0.030 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 35 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2016 | 31 | 0.030 |
Why?
|
Patient Selection | 1 | 2017 | 209 | 0.030 |
Why?
|
Osteoporosis | 1 | 2017 | 77 | 0.030 |
Why?
|
Vascular Resistance | 1 | 1995 | 13 | 0.030 |
Why?
|
Norepinephrine | 1 | 1995 | 30 | 0.030 |
Why?
|
Societies, Medical | 1 | 2016 | 152 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 1995 | 35 | 0.030 |
Why?
|
Markov Chains | 1 | 1995 | 32 | 0.030 |
Why?
|
Genetic Code | 1 | 1994 | 1 | 0.030 |
Why?
|
DNA Replication | 1 | 1994 | 10 | 0.030 |
Why?
|
Stress, Mechanical | 1 | 1995 | 170 | 0.030 |
Why?
|
Morphogenesis | 1 | 1994 | 8 | 0.030 |
Why?
|
Rivastigmine | 1 | 2014 | 1 | 0.030 |
Why?
|
Skin | 1 | 1995 | 116 | 0.030 |
Why?
|
Chronic Disease | 2 | 2009 | 442 | 0.030 |
Why?
|
Administration, Oral | 1 | 2014 | 110 | 0.030 |
Why?
|
Palliative Care | 1 | 1995 | 109 | 0.030 |
Why?
|
HIV Infections | 1 | 1999 | 486 | 0.030 |
Why?
|
Models, Genetic | 1 | 1992 | 35 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 1992 | 57 | 0.030 |
Why?
|
DNA | 1 | 1992 | 104 | 0.030 |
Why?
|
Phenotype | 1 | 2013 | 308 | 0.030 |
Why?
|
Coronary Disease | 1 | 1992 | 60 | 0.030 |
Why?
|
Sample Size | 1 | 2011 | 20 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2011 | 31 | 0.020 |
Why?
|
Age Distribution | 2 | 2004 | 90 | 0.020 |
Why?
|
Sex Distribution | 2 | 2004 | 81 | 0.020 |
Why?
|
Diastole | 2 | 2002 | 29 | 0.020 |
Why?
|
Databases, Factual | 1 | 2012 | 358 | 0.020 |
Why?
|
Ankle Joint | 1 | 2010 | 44 | 0.020 |
Why?
|
Clothing | 1 | 2009 | 3 | 0.020 |
Why?
|
Feedback, Physiological | 1 | 2009 | 13 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 2009 | 25 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2009 | 73 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2009 | 183 | 0.020 |
Why?
|
Forecasting | 2 | 2000 | 102 | 0.020 |
Why?
|
Homocysteine | 1 | 2005 | 8 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2006 | 166 | 0.020 |
Why?
|
Cholesterol | 1 | 2005 | 63 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2005 | 91 | 0.010 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2004 | 5 | 0.010 |
Why?
|
High-Frequency Ventilation | 1 | 2004 | 2 | 0.010 |
Why?
|
Electromyography | 1 | 2004 | 71 | 0.010 |
Why?
|
Rest | 1 | 2004 | 33 | 0.010 |
Why?
|
Hip Joint | 1 | 2010 | 549 | 0.010 |
Why?
|
Ventricular Dysfunction, Left | 2 | 1995 | 43 | 0.010 |
Why?
|
Physical Examination | 1 | 2004 | 119 | 0.010 |
Why?
|
Speech Disorders | 1 | 2003 | 11 | 0.010 |
Why?
|
Base Sequence | 2 | 1994 | 102 | 0.010 |
Why?
|
Motion | 1 | 2003 | 22 | 0.010 |
Why?
|
Videotape Recording | 1 | 2003 | 29 | 0.010 |
Why?
|
Alabama | 1 | 2002 | 1 | 0.010 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2002 | 3 | 0.010 |
Why?
|
Lung Volume Measurements | 1 | 2002 | 4 | 0.010 |
Why?
|
Cyclosporins | 1 | 2001 | 3 | 0.010 |
Why?
|
Drug Resistance, Multiple | 1 | 2001 | 11 | 0.010 |
Why?
|
Drug Interactions | 1 | 2001 | 38 | 0.010 |
Why?
|
Safety | 1 | 2001 | 44 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2001 | 50 | 0.010 |
Why?
|
Paclitaxel | 1 | 2001 | 44 | 0.010 |
Why?
|
Body Weight | 1 | 2001 | 145 | 0.010 |
Why?
|
Self Administration | 1 | 2000 | 21 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2002 | 140 | 0.010 |
Why?
|
Subliminal Stimulation | 1 | 2000 | 1 | 0.010 |
Why?
|
Internal-External Control | 1 | 2000 | 17 | 0.010 |
Why?
|
Research | 1 | 2000 | 43 | 0.010 |
Why?
|
Diagnostic Tests, Routine | 1 | 2000 | 13 | 0.010 |
Why?
|
Patient Compliance | 1 | 2001 | 165 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2000 | 66 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 1999 | 71 | 0.010 |
Why?
|
Organ Specificity | 1 | 1997 | 43 | 0.010 |
Why?
|
Sex Characteristics | 1 | 1999 | 120 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 1997 | 58 | 0.010 |
Why?
|
Anemia | 1 | 1999 | 94 | 0.010 |
Why?
|
Length of Stay | 1 | 2000 | 328 | 0.010 |
Why?
|
Oxidative Stress | 1 | 1997 | 107 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 1997 | 227 | 0.010 |
Why?
|
Least-Squares Analysis | 1 | 1995 | 8 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1995 | 37 | 0.010 |
Why?
|
Supine Position | 1 | 1995 | 21 | 0.010 |
Why?
|
Bias | 1 | 1995 | 40 | 0.010 |
Why?
|
Monte Carlo Method | 1 | 1995 | 53 | 0.010 |
Why?
|
Death, Sudden, Cardiac | 1 | 1995 | 14 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 1995 | 43 | 0.010 |
Why?
|
Survival Rate | 1 | 1995 | 356 | 0.010 |
Why?
|
Cardiac Output, Low | 1 | 1993 | 3 | 0.010 |
Why?
|
Mice | 1 | 1997 | 1467 | 0.010 |
Why?
|
Myosins | 1 | 1992 | 3 | 0.010 |
Why?
|
Caenorhabditis elegans | 1 | 1992 | 6 | 0.010 |
Why?
|
Introns | 1 | 1992 | 17 | 0.010 |
Why?
|
Biological Evolution | 1 | 1992 | 10 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1992 | 24 | 0.010 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1992 | 8 | 0.010 |
Why?
|
Hemodynamics | 1 | 1993 | 67 | 0.010 |
Why?
|
Chickens | 1 | 1992 | 34 | 0.010 |
Why?
|
Rats | 1 | 1992 | 678 | 0.010 |
Why?
|